# DoD Rare Cancers, Idea Development Award

Source: https://welltoldgrants.com/grants/w81xwh-22-rcrp-ida-dod-rare-cancers-idea-development-award/  
Official notice: https://www.grants.gov/search-results-detail/339628

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 15 awards worth $8.4 million in total. Applications closed on October 6, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-RCRP-IDA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 6, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 15 |
| Total funding | $8.4 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY22 RCRP Idea Development Award promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. Preliminary data with disease-specific rationale (may include correlatives studies to ongoing clinical research) to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/subtype(s) under study. Key elements of the Idea Development Award are as follows: • Innovation: Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities in the following ways: in concept or question, research methods or technologies, adaptations of existing methods or technologies, or other ways. Research that is likely to yield only an incremental advance is not considered innovative. • Impact: Research that has high potential impact may lead to major advancements and greatly improve outcomes for people with rare cancers.

## Questions people ask

### Is W81XWH-22-RCRP-IDA still open?

No. It closed on October 6, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Rare Cancers, Idea Development Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Rare Cancers, Idea Development Award?

Closed October 6, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $8.4 million in total across about 15 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.